All News

What is the state of value-based insurance design so far for 2014? According to a survey commissioned by McKesson and conducted by ORC International, pay-for-performance (P4P) is on the rise.

Integrated healthcare systems, with associated providers and health plans, have a leg up on implementing accountable care organizations to improve care and lower costs. Leaders from two Washington-based integrated systems shared some best practices and lessons learned for ACO success during a panel discussion Thursday at the AHIP Institute in Seattle.

After enduring a rhetorical bashing over the cost of hepatitis C wonder drug Sovaldi, drug manufacturers released a study this week documenting the high cost-sharing rates charged by some insurers on health plans sold through the public exchanges.

The FDA has approved the diagnostic agent technetium 99m tilmanocept for the detection of the spread of head and neck cancers.

Cutting edge technology used to image young children with heart disease increases their risk of cancer.

The Office of the National Coordinator (ONC) outlined a 10-year plan that will strengthen the nation's health IT infrastructure by 2024. This interoperable system would promote a "continuous learning" environment that would enforce higher-quality data standards, improve population health, better engage patients, and lower care delivery costs.

The drug industry scored a victory last month against the Obama administration's plans to give hospitals millions of dollars in discounts through the 340B program on orphan drugs. But HHS is sticking to its position that the Patient Protection and Affordable Care Act promises breaks on the expensive drugs when they're used for non-orphan indications.

Ventana Medical Systems, Inc. and MedImmune today announced they are jointly developing a PD-L1 (SP263) immunohistochemistry assay to enroll patients in clinical trials for MedImmune's MEDI4736 anti-PD-L1 therapy for non-small cell lung carcinoma. This includes the recently commenced MEDI4736 ATLANTIC trial that will enroll only patients who express PD-L1 as determined by the VENTANA assay.

Healthcare stakeholders suggest that the key to success for any accountable care organization (ACO) is its mix of data analytics and patient accountability.

New research suggests that a reduction in blood cholesterol might actually prove harmful in kidney cancer patients.

Some 59 percent have received meaningful use Stage 1 incentives.

Americans live in one of the most medically advanced societies in human history. But sometimes, there is no cure for what ails us.

Negotiating cash payments with medical providers outside the managed-care realm can save a bundle.

CYRAMZAâ„¢ (ramucirumab)did not meet its primary endpoint; overall survival favored the CYRAMZA arm but was not statistically significant, in patients with hepatocellular carcinoma, but meaningful improvements in key secondary endpoints of progression-free survival, overall response rate and time to progression were observed.

Pembrolizumab was safe and effective in patients with locally advanced or metastatic non—small cell lung cancer that strongly expressed PD-L1, according to study results presented at the ASCO Annual Meeting.

An analysis examining Medicare data found that the number of elderly beneficiaries receiving narcotic painkillers and anti-anxiety medications drastically increased from 2007 to 2012.

The U.S. House of Representatives passed legislation that makes it easier for patients to receive VA-paid treatment from their local doctors as a way to combat the longer waits for care at Veterans Affairs facilities.

The recent conversation regarding the abuse of prescription drugs that provide pain relief has some federal government officials calling this epidemic a "growing national crisis". While prescriptions such as Vicodin, OxyContin and other opioid drugs help patients with chronic pain, the White House is asking doctors to curtail their use of prescription opioids.

After an exceedingly high Medicaid enrollment this spring, Michigan became the second state to offer incentives and rewards for participants who agree to do health risk assessments with their physicians once a year as well as work to take the proper steps that improve their overall health.

A study conducted at the Johns Hopkins University demonstrates improved detection of prostate cancer metastasis following the injection of 18F-DCFBC, which binds PSMA.

The agreement will help develop Rosetta's thyroid neoplasia assay.

Personal health information may be key to reducing the costs of care. To work most efficiently, patient participation and compliance will be necessary.

Nearly 10% of women treated with herceptin were found to be susceptible to heart risks, which reversed once treatment was halted.

Autism exacts a heavy toll on families across the country, but what is the financial cost of the disorder?

Kathleen Sebelius handed leadership of the Health and Human Services Department to her successor on Monday and wished new Secretary Sylvia Matthews Burwell the best of luck.

Patients who want to compare prices for prostate-cancer surgery may find it rough going: a study has found a 13-fold difference in prices quoted by 100 hospitals across the United States. Moreover, most provided little more than broad estimates, and only three gave a hard copy of the charges.

The continued advances in cancer treatment are improving patient survival, but the healthcare industry is bursting at its seams.

Taiho Pharmaceutical Co., parent company of Taiho Oncology, announced recently that its combination drug for refractory metastatic colorectal cancer met its primary endpoint in a phase 3 global RECOURSE trial.